WS #12015

22:43→23:12 UTC

From 500 msgs · 5 key-dev

FDA approves subcutaneous version of Biogen's Leqembi for Alzheimer's, enabling at-home use and potentially boosting BIIB.

Biogen Leqembi Approval

FDA approves subcutaneous version of Biogen's Leqembi for Alzheimer's, enabling at-home use and potentially boosting BIIB.